ANGI-1 ASSESSING THE THERAPEUTIC EFFECT OF BEVACIZUMAB USING FMISO-PET IN GBM THERAPY

BACKGROUND: Gd-enhanced MRI and T2WI/FLAIR images are used to determine the efficacy of bevacizumab(Bev) in glioblastoma(GBM). FMISO-PET reflects hypoxia in tumor tissue. In this study, we hypothesized that FMISO-PET could detect a series of changes in the hypoxic environment during the Bev effect a...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Tomoya, Tanaka, Toshihide, Takei, Jun, Miyake, Keisuke, Suzuki, Kenta, Ogawa, Daisuke, Akasaki, Yasuharu, Yuichi, Murayama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719327/
http://dx.doi.org/10.1093/noajnl/vdac167.000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719327/
http://dx.doi.org/10.1093/noajnl/vdac167.000

Ejemplares similares